258 related articles for article (PubMed ID: 28787279)
1. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
Busca A; Parra-Herran C
Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
3. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
4. Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC; Bennett JA
Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
[TBL] [Abstract][Full Text] [Related]
5. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.
Hoang LN; Aneja A; Conlon N; Delair DF; Middha S; Benayed R; Hensley ML; Park KJ; Hollmann TJ; Hameed MR; Antonescu CR; Soslow RA; Chiang S
Am J Surg Pathol; 2017 Jan; 41(1):12-24. PubMed ID: 27631520
[TBL] [Abstract][Full Text] [Related]
6. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
7. Fibromyxoid variant of endometrial stromal sarcoma with atypical bizarre nuclei.
Kim HS; Yoon G; Jung YY; Lee YY; Song SY
Int J Clin Exp Pathol; 2015; 8(3):3316-21. PubMed ID: 26045860
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
9. PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.
Chiang S; Samore W; Zhang L; Sung YS; Turashvili G; Murali R; Soslow RA; Hensley ML; Swanson D; Dickson BC; Stewart CJR; Oliva E; Antonescu CR
Am J Surg Pathol; 2019 Jun; 43(6):810-818. PubMed ID: 30829727
[TBL] [Abstract][Full Text] [Related]
10. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
Oliva E; Clement PB; Young RH
Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
[TBL] [Abstract][Full Text] [Related]
11. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
[TBL] [Abstract][Full Text] [Related]
12. Uterine mesenchymal tumours: recent advances.
Momeni-Boroujeni A; Chiang S
Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
[TBL] [Abstract][Full Text] [Related]
13. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
14. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
Rommel B; Holzmann C; Bullerdiek J
Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
[TBL] [Abstract][Full Text] [Related]
15. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
[TBL] [Abstract][Full Text] [Related]
16. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054
[TBL] [Abstract][Full Text] [Related]
18. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
Alkanat NE; Uner A; Usubutun A
Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
[No Abstract] [Full Text] [Related]
19. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
